Entrada Therapeutics, Inc.: Form 8-K, filed Nov 7, 2022
Filed with the SEC on Nov 7, 2022 and accepted by EDGAR at Nov 7, 2022, 07:24 ET.
Items reported
- Item 2.02 Results of operations
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Source: SEC EDGAR, the filing index for accession 0001689375-22-000043. Last ingested by Listed: Nov 5, 2026, 11:57 ET. Listed shows no prices and gives no investment advice.